What does Evofem Biosciences, Inc. (EVFM) do?

Evofem Biosciences, Inc. (EVFM) is a publicly traded company in the Healthcare sector.

What sector does EVFM operate in?

Evofem Biosciences, Inc. operates in the Healthcare, specifically within the Pharmaceutical Preparations industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find EVFM earnings analysis?

AlphaOS publishes an earnings intelligence page for Evofem Biosciences, Inc. (EVFM) covering results, guidance context, and AI-assisted analysis. See /stocks/EVFM/earnings. Content is for research and education — not investment advice.

Coverage building

EVFM has basic price and filing data (45% intelligence coverage), but earnings analysis, financial metrics, and proprietary signals are still building. Explore a peer with deeper coverage below.

Deeper coverage nearby

Intelligence coverage: 45%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

EVFM

Evofem Biosciences, Inc.

Healthcare · Pharmaceutical Preparations

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Evofem Biosciences, Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue -46% YoY in Q2 FY2026.

TrajectoryDecelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue -46% YoY in Q2 FY2026

Pipeline evidence · 0d ago

EVFM's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on EVFM.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full EVFM earnings analysis

Reported figures for Evofem Biosciences, Inc. — research only, not investment advice.

Revenue YoY: -45.5%

Latest Intelligence

Updated September 29, 2026

What happened recently for Evofem Biosciences, Inc. (EVFM) — events, not interpretation.

Event: Reported Q2 2026 revenue -46% YoY.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

Evofem Biosciences, Inc. (EVFM)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Evofem Biosciences, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceutical Preparations
Revenue:: $16.84M

EVFM earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Evofem Biosciences, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Hub Cyber Security Ltd.90% confidencerelated

Connected companies and research pages from the AlphaOS knowledge graph.